Two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong, Shenzhen and a pharmaceutical start-up founded by a former lawmaker. The agreement was formalised on Tuesday when Health Hope Pharma founder Dr Dennis Lam Shun-chiu signed a memorandum of understanding with the Greater Bay Area International Clinical Trial Institute (GBAICTI) and its Shenzhen counterpart, Greater Bay...
The matter relates to a woman in Kerala, who was suffering from breast cancer and had moved the State High Court challenging the exorbitant prices of medicine for treatment. She died during the pendency of the plea in the high court.
The case has been pending before the Kerala High Court since June 2022; the writ petition has been listed 57 times for final hearing without the case being heard since January 21, 2023, the Working Group on Access to Medicines and Treatment says in its letter